Cancer clinical trials in the region Île-de-France

775 currently recruiting clinical trials
Region Île-de-France
Phase 3 Lymphoma #NCT06091254 #2022-502660-20-00
Required histologic types
B cell lymphoma
Required histologic sub types
Follicular lymphoma
Required disease stage
Disseminated (stage III and IV)
Required immunophenotypic profiles
CD20
Required number of previous lines of therapy
None
Required previous treatments
Systemic Treatment-Naive
9 recruiting sites
Regeneron Pharmaceuticals
Phase 3 Pancreas cancer #NCT07591493 #2025-523593-16-00
Required histologic sub types
Neuroendocrine tumor
Required disease stage
Localized Locally Advanced
Required number of previous lines of therapy for current stage of disease
None
Required previous treatments at localized stage
Systemic Treatment-Naive Surgery
Required previous treatments at advanced or metastatic stage
Systemic Treatment-Naive Surgery
1 recruiting site
Gustave Roussy, Campus du cancer, Grand Paris
Phase 3 Ovarian / Fallopian tubes / Peritoneum cancer #NCT06819007 #2024-516982-35-00
Required histologic types
Epithelial ovarian cancer Fallopian tube cancer Primary peritoneal cancer (PPC)
Required histologic sub types
Serous high grade carcinoma (HGSOC) Endometrioid carcinoma Clear cell carcinoma Mucinous carcinoma Other epithelial ovarian cancer
Required FIGO stages
Stage III Stage IV
Required disease stage
Locally Advanced Metastatic
Required genetic anomalies
HER2
Required number of previous lines of therapy for current stage of disease
None
Excluded genetic anomalies
BRCA 1/2
10 recruiting sites
Daiichi Sankyo
Phase 3 Sarcoma and GIST #NCT06127407 #2023-508507-20-00
Required histologic types
Bone sarcoma
Required histologic sub types
Chondrosarcoma
Required disease stage
Locally Advanced Metastatic
Required number of previous lines of therapy for current stage of disease
None 1 2
Required previous treatments at advanced or metastatic stage
Systemic Treatment-Naive Chemotherapy Targeted therapy
Required sarcoma grades
Grade 1 Grade 2 Grade 3
9 recruiting sites
Phase 3 Endometrial cancer #NCT07022483 #2024-519444-33-00
Required histologic sub types
Endometrioid adenocarcinoma Serous adenocarcinoma Clear cell carcinoma Dedifferentiated and undifferentiated endometrial ... Carcinosarcoma
Required FIGO stages
Stage II Stage III
Required disease stage
Localized Locally Advanced
Required genetic anomalies
HER2
Required number of previous lines of therapy for current stage of disease
None
Required previous treatments at localized stage
Systemic Treatment-Naive
Required previous treatments at advanced or metastatic stage
Systemic Treatment-Naive
Excluded genetic anomalies
POLE
6 recruiting sites
Daiichi Sankyo
Phase 3 Head and neck cancer #NCT06798922
Required histologic types
Oral cavity Oropharynx
Required disease stage
Localized
Required number of previous lines of therapy for current stage of disease
None
Required previous treatments at localized stage
Surgery
2 recruiting sites
Centre François Baclesse
Phase 3 Bladder / Urinary Tract / Urethral cancer #NCT06319820 #2023-507684-19-00
Required histologic types
Non-invasive bladder cancer
Required histologic sub types
Urothelial carcinoma
Required disease stage
Localized
Required genetic anomalies
FGFR
8 recruiting sites
Janssen
Phase 3 Bladder / Urinary Tract / Urethral cancer #NCT06319820 #2023-507684-19-00
Required histologic types
Non-invasive bladder cancer
Required histologic sub types
Urothelial carcinoma
Required disease stage
Localized
Required genetic anomalies
FGFR
Required number of previous lines of therapy for current stage of disease
None
Required previous treatments at localized stage
Systemic Treatment-Naive
8 recruiting sites
Janssen
Phase 3 Head and neck cancer #NCT07276399 #2025-521917-24-00
Required histologic types
Oral cavity Oropharynx Hypopharynx Larynx
Required histologic sub types
Squamous cell carcinoma
Required disease stage
Locally Advanced Metastatic
Required number of previous lines of therapy for current stage of disease
None
Required previous treatments at advanced or metastatic stage
Systemic Treatment-Naive
9 recruiting sites
Janssen
Phase 3 Pancreas cancer #NCT07409272 #2025-523684-38-00
Required histologic sub types
Adenocarcinoma
Required disease stage
Metastatic
Required genetic anomalies
KRAS G12D
Required number of previous lines of therapy for current stage of disease
None
Required previous treatments at advanced or metastatic stage
Systemic Treatment-Naive
10 recruiting sites
Astellas Pharma Développement mondial, Inc.